Citi: Buy Celgene, Gilead, Biogen And Regeneron As Biotechs Recover
February 25, 2016 at 08:51 AM EST
Citi’s Robyn Karnauskas said that while the fundamentals of large-cap biotech stocks remained intact, a full recovery could ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.